Search

everythinglearnresearchcommunity

for

Search:↓

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Gray hair can potentially be reversed, leading to new treatments.

Early diagnosis is crucial for treating alopecia effectively.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Apremilast shows promise for several skin conditions but needs more research.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.